Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: A double-blind randomized study

British Journal of Haematology

Volumn 96, Issue 1, 1997, Pages 174-178

  Tardy, Bernard ^a,b   Tardy Poncet, Brigitte ^a   Laporte Simitsidis, Silvy ^a   Mismetti, Patrick ^a   Decousus, Hervé ^a   Guyotat, Denis ^a   Bertrand, Jean C ^a  

^a Department of Intensive Care   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

hypercoagulable state; oral anticoagulant; venous thrombosis; withdrawal

Indexed keywords

ACENOCOUMAROL; D DIMER; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; THROMBOSIS;

ACENOCOUMAROL; BLOOD COAGULATION; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYSIS; HUMANS; MALE; RECURRENCE; THROMBOEMBOLISM; TIME FACTORS;

EID: 0031027329     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.8752506.x     Document Type: Article

References (14)

1. Bauer, K.A. & Rosenberg, R.D. (1987) The pathophysiology of the prethrombotic state in humans: insights from studies using markers of hemostatic system activation. Blood, 70, 343-350.
2. Bauer, K.A., Weiss, L.M., Sparrow, D., Vokonas, P.S. & Rosenberg, R.D. (1987) Aging associated changes in indices of thrombin generation and protein C activation on humans. Journal of Clinical Investigation, 80, 1527-1534.
3. Cadroy, Y., Pierrejean, D., Fontan, B., Sié, P. & Boneu, B. (1992) Influence of aging on the activity of the hemostatic system: prothrombin fragments 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouvelle Revue Française d'Hématologie, 34, 43-46.
4. Conway, E.M., Bauer, K.A., Barzegar, S. & Rosenberg, R.D. (1987) Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. Journal of Clinical Investigation, 80, 1535-1544.
5. Dinon, L.R. & Vander Veer, J.B. (1960) Recurrent myocardial infarction after cessation of anticoagulant therapy. American Heart Journal, 60, 6-22.
6. Genewein, U., Haeberli, A., Straub, P.W. & Beer, J.H. (1996) Rebound after cessation of oral anticoagulant therapy: the biochemical evidence, British Journal of Haematology, 92, 479-485.
7. Grip, L., Blombäck, M. & Schulman, S. (1991) Hypercoagulable state and thromboembolism following warfarin withdrawal in postmyocardial infarction patients. European Heart Journal, 12, 1225-1233.
8. Harenberg, J., Haas, R. & Zimmermann, R. (1983) Plasma hypercoagulability after termination of oral anticoagulants. Thrombosis Research, 29, 627-633.
9. Hirsh, J., Dalen, J.E., Deykin, D., Poller, L. & Busseu, H. (1995) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 108, 231S-246S.
10. Mannuci, P.M., Botasso, B., Tripodi, A. & Bonomi, A.B. (1991) Prothombin fragment 1+2 and intensity of treatment with oral anticoagulants. Thrombosis and Haemostasis, 66, 741.
11. Palareti, G., Legnani, C., Guazzaloca, G., Frascaro, M., Grauso, F., De Rosa, F., Fortunato, G. & Coccheri, S. (1994) Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants: a prospective study. Thrombosis and Haemostasis, 72, 222-226.
12. Poller, L. & Thomson, J.M. (1994) Evidence for rebound hypercoagulability after stopping anticoagulants. Lancet, ii, 62-64.
13. Schofield, K.P., Thomson, J.M. & Poller, L. (1987) Protein C response to induction and withdrawal of oral anticoagulant treatment. Clinical and Laboratory Haematology, 9, 255-262.
14. Van Werch, J.W.J. & Van Mourk-Alderliesten, C.H. (1993) Fibrinolysis and oral anticoagulation. Fibrinolysis, 7, 47-49.